Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Vitiligo Treatment Strategies: Addressing Skin of Color Considerations, Long-Term Regimentation, and Disease Management
Andrew Alexis, MD, MPH, presents the case of a 60-year-old man with a 5-year history of vitiligo who received topical ruxolitinib 1.5% cream and achieved gradual repigmentation over a six-month period.
Now Viewing
EP: 1.Vitiligo Treatment Strategies: Addressing Skin of Color Considerations, Long-Term Regimentation, and Disease Management
EP: 2.Differentiating Clinical Markers in Vitiligo: Managing Unstable Disease and Depigmented Macules
EP: 3.Overcoming Treatment Barriers in Vitiligo: From Insurance Coverage to Patient Adherence
Video content above is prompted by the following questions:
- What is your impression of this case?
- What challenges does this case present with, if any?
- How do you decide when to consider transitioning to a different treatment vs continuing the current course?
- How would you approach the next steps of treatment for this patient?
Recent Videos
Related Content
